BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31021398)

  • 1. Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.
    Zieman AG; Coulombe PA
    Br J Dermatol; 2020 Mar; 182(3):564-573. PubMed ID: 31021398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.
    Zieman AG; Poll BG; Ma J; Coulombe PA
    Hum Mol Genet; 2019 Jul; 28(13):2255-2270. PubMed ID: 31220272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes.
    Kerns ML; Hakim JM; Lu RG; Guo Y; Berroth A; Kaspar RL; Coulombe PA
    J Clin Invest; 2016 Jun; 126(6):2356-66. PubMed ID: 27183391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders.
    Lessard JC; Coulombe PA
    J Invest Dermatol; 2012 May; 132(5):1384-91. PubMed ID: 22336941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
    Samuelov L; Smith FJD; Hansen CD; Sprecher E
    Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large mutational study in pachyonychia congenita.
    Wilson NJ; Leachman SA; Hansen CD; McMullan AC; Milstone LM; Schwartz ME; McLean WH; Hull PR; Smith FJ
    J Invest Dermatol; 2011 May; 131(5):1018-24. PubMed ID: 21326300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma.
    Du ZF; Xu CM; Zhao Y; Liu WT; Chen XL; Chen CY; Fang H; Ke HP; Zhang XN
    Eur J Dermatol; 2012; 22(4):476-80. PubMed ID: 22668561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual Dimorphism in Response to an NRF2 Inducer in a Model for Pachyonychia Congenita.
    Kerns ML; Hakim JMC; Zieman A; Lu RG; Coulombe PA
    J Invest Dermatol; 2018 May; 138(5):1094-1100. PubMed ID: 29277538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.
    Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY
    Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children.
    Goldberg I; Mashiah J; Kutz A; Derowe A; Warshauer E; Schwartz ME; Smith F; Sprecher E; Hansen CD
    Br J Dermatol; 2020 Mar; 182(3):708-713. PubMed ID: 31777952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular genetic analysis of the expanding pachyonychia congenita case collection.
    Wilson NJ; O'Toole EA; Milstone LM; Hansen CD; Shepherd AA; Al-Asadi E; Schwartz ME; McLean WH; Sprecher E; Smith FJ
    Br J Dermatol; 2014 Aug; 171(2):343-55. PubMed ID: 24611874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized bullae in a young girl with KRT6A-related pachyonychia congenita.
    Liu J; Zhong W; Yu B; Lin Z; Zheng Y; Hu X
    Pediatr Dermatol; 2020 Sep; 37(5):974-976. PubMed ID: 32662074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling reveals KRT6C as a probable hereterodimer partner for KRT9: New insights into re-classifying epidermolytic palmoplantar keratoderma (EPPK) and a milder form of pachyonychia congenita (PC-K6c) as a group of genetic cutaneous disorders.
    Li P; Qi J; Zhong Y; Ding A; Xiao H
    J Proteomics; 2023 Sep; 287():104971. PubMed ID: 37467889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First case of pachyonychia congenita in the Czech Republic.
    Jiráková A; Rajská L; Rob F; Džambová M; Sečníková Z; Göpfertová D; Schwartz M; Smith F; Lotti T; Hercogová J
    Dermatol Ther; 2015; 28(1):10-2. PubMed ID: 25174302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
    Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
    Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of clinically useful predictive genetic variants in pachyonychia congenita.
    Samuelov L; Sarig O; Adir N; Pavlovsky M; Smith FJ; Schwartz J; Hansen CD; Sprecher E
    Clin Exp Dermatol; 2021 Jul; 46(5):867-873. PubMed ID: 33486795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The keratin 16 null phenotype is modestly impacted by genetic strain background in mice.
    Zieman A; Coulombe PA
    Exp Dermatol; 2018 Jun; 27(6):672-674. PubMed ID: 29406601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A KRT16 mutation in the first Chinese pedigree with Pachyonychia congenita and review of the literatures.
    Xu Q; Zhang Q; Tang L; Jin L; Wang X; Kan L; Zheng X; Yang S
    J Cosmet Dermatol; 2019 Dec; 18(6):1930-1934. PubMed ID: 30859684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin 17 Mutations in Four Families from India with Pachyonychia Congenita.
    Agarwala M; Salphale P; Peter D; Wilson NJ; Pulimood S; Schwartz ME; Smith FJD
    Indian J Dermatol; 2017; 62(4):422-426. PubMed ID: 28794556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.
    Eliason MJ; Leachman SA; Feng BJ; Schwartz ME; Hansen CD
    J Am Acad Dermatol; 2012 Oct; 67(4):680-6. PubMed ID: 22264670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.